Upcoming drug targets for kidney protective effects in chronic kidney disease
➡️This review describes the new and promising treatments for CKD. These therapies hold the potential to slow kidney disease and improve the wellbeing of patients.
🔓doi.org/10.1093/ndt/gf…
The latest 2025 #Hypertension Guidelines are out 📣
#Nephpearls
📌 Use of risk-based thresholds for initiation of BP treatment
📌 BP thresholds and recommendations for treatment and follow-up
📌 Screening for features suggesting secondary hypertension
👉🏼…
Now open access in @NDTsocial
Anti-nephrin, anti-podocin and anti-Kirrel1 antibodies: Biological challenges and clinical implications
🧐 Clinical implementation of anti-slit diaphragm antibody testing = precision dx and tx in podocytopathies
▶️academic.oup.com/ndt/article/do…
@sciqst@SciReports Reposted with correct ✅ first page
Urine sodium (Urine Na) levels post-saline infusion in differentiating non-edematous hyponatremia ca. 2025 from @SciReports#Nephpearls
📌 Administering a saline infusion before measuring Urine Na may improve diagnostic accuracy by…
Now online in @NDTsocial
Perlecan is a novel target of autoantibodies in anti-glomerular basement membrane disease
🧐Triple-positive pts (anti-type IV collagen, -laminin 521, and -perlecan) = highest prevalence of lung hemorrhage and ESKD
▶️academic.oup.com/ndt/article-ab…
#Endocrinología#MedicinaInterna
Algoritmo de infusión continua de insulina de la Universidad de Emory para el tratamiento de hiperglucemia en el contexto perioperatorio.
Nat Rev Endocrinol. 2025. doi:10.1038/s41574-025-01157-1
558 Followers 3K FollowingPhysician with a secret mission:Guardian of glomeruli 🇺🇸. Engaging in sharing interesting tweets. Retweets are not a full endorsement unless stated.
291 Followers 335 FollowingSpecialist Nephrologist & Professor, President, Sri Lanka Society of Nephrology, Chair, ISN i3C working group, Member of ISN South Asian Regional Board
3K Followers 3K FollowingNephrologist. Prof. @MayoClinic Focused on AI, Big Data & ML in Kidney Diseases & Transplantation. Advancing tech-driven healthcare solutions. #Nephrology
2K Followers 3K FollowingYour trusted partner for nephrology specific career guidance, practice growth, and physician placement. #USRenaLink #nephcareers
3K Followers 2K FollowingNephrology Business Leadership https://t.co/ZJGs7Ys7zP for Senior Nephrology Fellows; Hosts Dallas Renal Group, US Renal Care, UC San Diego & Neph Leaders #NBLUniv
3K Followers 3K Following#Nephrologist @SLUHospital, researcher, advocate for advancing care of #transplant patients and #LivingDonors. Opinions are my own, and are not medical advice.
828 Followers 2K Following🙌🏾'#APOL1 Long-term #KidneyTransplantation Outcomes’ (#APOLLO) Network is an @NIH-supported study working to address #RacialDisparities in kidney transplant
33K Followers 125 FollowingChicago Sports Fan... Nephrologist by day. My tweets are not medical advice. The views expressed here are my own and not those of my employer.
137 Followers 2 FollowingNSE Indices Limited (formerly known as India Index Services & Products Ltd. - IISL), a subsidiary of NSE, provides a variety of indices & index related services
282K Followers 18 FollowingFounder, @investyadnya. An Investor & Author - 1) 108 Ques & Ans on Mutual Funds & SIP 2) How to manage your Retirement Corpus https://t.co/DGZNf5YJYa
492K Followers 15 FollowingChemical Engr. Full time FNO Trader since Dec. 2017.. Views only for learning. No Paid Tips. No Telegram. Old telegram channel Inactive.
779K Followers 37 FollowingZEE BUSINESS is India’s Number 1 Hindi business news channel. It's your channel for profit and wealth. Download App - https://t.co/yoRVtU3uFg
318K Followers 185 FollowingSmallcase: https://t.co/rtMQMaLAe9 For detailed disclaimers, disclosures and other registration details: https://t.co/rJSLEC7PHF
141K Followers 14 FollowingAvid Reader | Data-Driven Research & Analysis | SEBI Unregistered | Let Data Speak Louder Than Words | Sharing insights freely for better investing.
311K Followers 666 FollowingFounding Editor @TheNewsPinch | Ex Associate Editor Lallantop | Ex-ABP | IIMC | AU | भारत की सच्ची बात, भारत का राग।|शब्द ही शस्त्र,पत्रकारिता ही धर्म |
5K Followers 501 FollowingGlomConILA es una plataforma para que la comunidad renal de Latinoamérica, España y Portugal intercambie ideas, participe en conferencias en línea y colabore.
67K Followers 340 FollowingCapturing momentum, earnings plays, bases, new trends, and even those daring falling knives
My tweets are personal journal entries, not recommendations
71K Followers 578 FollowingInvestor/Trader using Trendlines, CCI, RS | Head of Product |
Not SEBI reg - Content for educational purpose
https://t.co/PBp8Ylfpat
444K Followers 2K FollowingFounder: Omkara Capital. Ex- Fund Manager. Ex-Head Of Research & Corporate Editor, CNBC India. Mission: Building wealth slowly, steadily but surely with Omkara
204K Followers 99 FollowingFounder - Plutus Advisors | SEBI Registered Research Analyst - Plutus Advisors | Investor | Big Data | Quant | Technofunda | 18+ Years of Experience
360K Followers 101 FollowingMkt Participant. Ex Biz Journalist. Views are personal. Invested so consult advisor before u trade on my views. Tweets, retweets not recos. Not SEBI registered
85K Followers 523 FollowingWelcome to E*TRADE from Morgan Stanley. Follow us for financial insights, commentary, product news and educational events. Disclosure: https://t.co/2ubRZpLGfH
729K Followers 219 FollowingOfficial account of Morgan Stanley. We provide a range of investment banking, securities, investment management & wealth management services worldwide.
2K Followers 909 FollowingA professional society for glomerular disease experts, founded 2022. President @Tobias_B_Huber
Español @ISGD_la
🦋 https://t.co/uXHF9301vy
204 Followers 71 FollowingInterests Renal Path tx infection wrote"Pathology of Glomerular dis."
Pathology of opportunistic infection Atlas Springer
Dream Plan Execute
❤ to make friends
268K Followers 874 FollowingManaging Editor, CNBC-Awaaz and CNBC-Bajar Previously, Stocks Editor, CNBC-TV18. One of India's most trusted and seasoned stock market anchors.